COR
Cencora, Inc.
324.80
120 x 319.80
120 x 324.89
bid
ask
+
7.14
2.25%
120 @ 04:00 PM
324.81 +0.01 (0.00%)
Ytd -3.83%
1y 16.20%
314.36
day range
324.86
273.89
52 week range
374.75
Open 317.32 Prev Close 317.66 Low 314.36 High 324.86 Mkt Cap 63.18B
Vol 971.20K Avg Vol 1.35M EPS 8.31 P/E 39.09 Forward P/E 16.54
Beta 0.65 Short Ratio 4.92 Inst. Own 96.84% Dividend 2.40 Div Yield 0.76
Ex Div Date 02-13 Earning 05-06 50-d Avg 349.02 200-d Avg 326.24 1yr Est 407.92
Earning
Date For Estimate Reported Surprise surprise %
2026-05-06 2026-03 4.83 N/A N/A N/A
2026-02-04 2025-12 4.07 4.08 0.01 0.25%
2025-11-05 2025-09 3.79 3.84 0.05 1.32%
2025-08-06 2025-06 3.78 4 0.22 5.82%
2025-05-07 2025-03 4.08 4.42 0.34 8.33%
2025-02-05 2024-12 3.5 3.73 0.23 6.57%
Upgrade / Downgrade
Date Firm Action From To
2026-02-13 Barclays Upgrade Overweight Overweight
2026-02-10 JP Morgan Upgrade Overweight Overweight
2026-02-10 Wells Fargo Upgrade Overweight Overweight
2026-02-05 Evercore ISI Group Upgrade Outperform Outperform
2026-01-29 Morgan Stanley Upgrade Equal-Weight Overweight
2026-01-22 Jefferies Upgrade Hold Buy
Profile
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Insider Holder
Date Name Relation Quantity Description
2026-03-10 BATTAGLIA SILVANA Officer 23.57K Conversion of Exercise of derivative security
2026-03-10 CAMPBELL ELIZABETH S Officer 30.71K Conversion of Exercise of derivative security
2026-03-10 CLEARY JAMES F. JR. Chief Financial Officer 160.36K Conversion of Exercise of derivative security
2025-09-15 COLLIS STEVEN H Officer and Director 305.91K Conversion of Exercise of derivative security
2026-03-04 DURCAN DERMOT MARK Director 23.77K Stock Award(Grant)
2026-03-04 GREENBERG LON R Director 18.41K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 23.62M 7.67B 12.14%
2025-12-30 Blackrock Inc. 20.29M 6.59B 10.43%
2025-12-30 State Street Corporation 9.31M 3.02B 4.78%
2025-12-30 Price (T.Rowe) Associates Inc 6.99M 2.27B 3.59%
2025-12-30 T. Rowe Price Investment Management, Inc. 6.70M 2.18B 3.44%
2025-12-30 Geode Capital Management, LLC 5.46M 1.77B 2.81%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 5.79M 1.88B 2.97%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 4.89M 1.59B 2.51%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 4.01M 1.30B 2.06%
2025-12-30 T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App 2.73M 885.78M 1.40%
2026-01-30 VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund 2.63M 855.10M 1.35%
2026-01-30 iShares Trust-iShares Core S&P 500 ETF 2.49M 810.33M 1.28%
Dividend
Dividend Date
0.6 2026-02-13
0.6 2025-11-14
0.55 2025-08-15
0.55 2025-05-16
0.55 2025-02-14
0.55 2024-11-15
Split
Split Date
10 : 1 2014-06-13